Enzyme assays for lysosomal enzymes such as beta-glucocerebrosidase and alpha-galactosidase A are registered in the GTR and can be applied for guided treatment with Velaglucerase alfa in type 1 Gaucher disease (GD) and Migalastat in Fabry disease respectively. Here, GBA1 is linked to Fabry disease.